Anna U. Loengard - Mar 14, 2024 Form 4 Insider Report for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Role: Director
Signature: /s/Peter J. Rivas as attorney-in-fact for Anna U. Loengard
Stock symbol: CLOV
Transactions as of: Mar 14, 2024
Transactions value $: $109,956
Form type: 4
Date filed: 3/18/2024, 04:30 PM
Previous filing: Jan 5, 2024
Next filing: May 20, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CLOV	Class A Common Stock	Purchase	$100K	+137K	+34.09%	$0.73	539K	Mar 14, 2024	Direct	F1
transaction	CLOV	Class A Common Stock	Purchase	$9.95K	+13.6K	+908.33%	$0.73	15.1K	Mar 14, 2024	By Daughter in a Custodial Account
holding	CLOV	Class A Common Stock						10K	Mar 14, 2024	By Spouse IRA
holding	CLOV	Class A Common Stock						1.3K	Mar 14, 2024	By Son in a Custodial Account

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average purchase price. These shares were purchased on the Transfer Date in multiple transactions at prices ranging from $0.73 to $0.74 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average purchase price. These shares were purchased on the Transfer Date in multiple transactions at prices ranging from $0.73 to $0.74 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.